In last trading session, Guardant Health Inc (NASDAQ:GH) saw 1.22 million shares changing hands with its beta currently measuring 1.51. Company’s recent per share price level of $43.49 trading at $1.02 or 2.40% at ring of the bell on the day assigns it a market valuation of $5.37B. That closing price of GH’s stock is at a discount of -17.02% from its 52-week high price of $50.89 and is indicating a premium of 63.65% from its 52-week low price of $15.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.56 million shares which gives us an average trading volume of 2.36 million if we extend that period to 3-months.
For Guardant Health Inc (GH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.48. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 13 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Guardant Health Inc (NASDAQ:GH) trade information
Upright in the green during last session for gaining 2.40%, in the last five days GH remained trading in the red while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $43.49 price level, adding 7.23% to its value on the day. Guardant Health Inc’s shares saw a change of 42.36% in year-to-date performance and have moved -5.13% in past 5-day. Guardant Health Inc (NASDAQ:GH) showed a performance of 4.85% in past 30-days. Number of shares sold short was 8.35 million shares which calculate 3.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 52 to the stock, which implies a rise of 16.37% to its current value. Analysts have been projecting 52 as a low price target for the stock while placing it at a high target of 52. It follows that stock’s current price would drop -19.57% in reaching the projected high whereas dropping to the targeted low would mean a loss of -19.57% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -33.61% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 19.03% while estimates for its earnings growth in next 5 years are of 17.52%.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Insiders are in possession of 4.74% of company’s total shares while institution are holding 98.66 percent of that, with stock having share float percentage of 103.56%. Investors also watch the number of corporate investors in a company very closely, which is 98.66% institutions for Guardant Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at GH for having 11.64 million shares of worth $336.07 million. And as of 2024-06-30, it was holding 9.5609 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 11.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.1777 of outstanding shares, having a total worth of $324.55 million.
